The excessive daytime sleepiness market drowsiness was projected to be worth USD 4.9 billion in 2022. With an expected CAGR of 8.8% from 2023 to 2033, this market is expected to earn USD 5.33 billion ...
Sleep apnoea is common among older adults but is often overlooked or ignored leading to delayed diagnosis and treatment ...
A similar therapy is called bilevel, or BiPAP, but it differs in important ways. The “bilevel” component refers to the fact that there are two pressures, which the machine is able to alternate between ...
ResMed launches AirSense 11, to advance digital health in sleep apnoea for Indians: Our Bureau, Bengaluru Monday, January 6, 2025, 17:30 Hrs [IST] ResMed, the world’s leading he ...
Newsable Asianet News on MSN13d
Weight loss drug Zepbound gets US FDA nod to treat sleep apnea; India launch expected in 2025Currently, the main treatments for moderate to severe OSA involve the use of assistive breathing devices such as Continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results